FDA and Novo Nordisk alert consumers to counterfeit Ozempic

The U.S. Food and Drug Administration and the pharmaceutical company Novo Nordisk are urging consumers to be on the lookout for counterfeit Ozempic (semaglutide) and to refrain from using the imitation drugs.

Leave A Comment

Your email address will not be published. Required fields are marked *